Question 1

How many shares of EIGR does CITADEL ADVISORS LLC own?

Accepted Answer

CITADEL ADVISORS LLC previously held 0 shares of EIGR (EIGER BIOPHARMACEUTICALS INC) before exiting the position in 2024-Q1.

Question 2

What is CITADEL ADVISORS LLC's EIGR position worth?

Accepted Answer

CITADEL ADVISORS LLC's EIGR position was last reported at $0 in 2024-Q1 before the exit.

Question 3

Is CITADEL ADVISORS LLC buying or selling EIGR?

Accepted Answer

In 2024-Q1, CITADEL ADVISORS LLC exited their EIGR position entirely (-100.0% change in shares).

Question 4

When did CITADEL ADVISORS LLC first buy EIGR?

Accepted Answer

Based on available 13F filings, CITADEL ADVISORS LLC first reported a position in EIGR in 2019-Q2. They have held the position across 17 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2024-Q1 Latest	Exited	0	-100.0%	$0	0.0%	—	0
2023-Q4	New	10,008	-	$2,247	0.0%	—	18
2023-Q1	Exited	0	-100.0%	$0	0.0%	—	0
2022-Q4	Increased	120,680	+52.6%	$142,402	0.0%	—	21
2022-Q3	New	79,088	-	$595,000	0.0%	—	34
2022-Q1	Exited	0	-100.0%	$0	0.0%	—	0
2021-Q4	Increased	119,109	+96.6%	$618,000	0.0%	—	39
2021-Q3	New	60,577	-	$405,000	0.0%	—	33
2021-Q2	Exited	0	-100.0%	$0	0.0%	—	0
2021-Q1	Decreased	889,949	-6.3%	$7.9M	0.0%	—	0
2020-Q4	Increased	949,302	+7.0%	$11.7M	0.0%	—	30
2020-Q3	Increased	887,305	+0.5%	$7.2M	0.0%	—	27
2020-Q2	Increased	883,300	+3.5%	$8.5M	0.0%	—	28
2020-Q1	Increased	853,282	+96.0%	$5.8M	0.0%	—	43
2019-Q4	Increased	435,353	+1.3%	$6.5M	0.0%	—	28
2019-Q3	Increased	429,924	+43.9%	$4.4M	0.0%	—	36
2019-Q2	New	298,828	-	$3.2M	0.0%	—	37

EIGR17 quarters

EIGR
17 quarters